Literature DB >> 18973510

Percutaneous mechanical thrombectomy for massive pulmonary embolism using a conservative treatment strategy.

Christian Spies1, Abha Khandelwal, Timothy H Smith, Neeraj Jolly, Clifford J Kavinsky.   

Abstract

INTRODUCTION: Percutaneous mechanical thrombectomy (PMT) for treatment of massive pulmonary embolism (PE) has been shown to be technically feasible, although the complication rate of the procedure appears relatively high. Whether a conservative treatment approach defined by an early termination of the PMT procedure once hemodynamic and clinical parameters of the patient have improved is associated with lower complication rates is unknown. We report our experience of PMT in patients with massive PE using the Angiojet system following a conservative treatment strategy.
METHODS: From April 2003 until November 2007, 13 patients underwent PMT with the Angiojet system. Indications for PMT were massive PE and either failed thrombolysis or contraindications to thrombolytic therapy. All patients were deemed high risk for surgical thrombectomy.
RESULTS: Technical success was achieved in 12 patients (92%). Mean systemic arterial pressure increased from 87 to 106 mmHg following PMT (P = 0.011), while the heart rate decreased from 119 to 97 beats per minute (P = 0.041). In-hospital mortality was 15% (2 of 13 patients). No complications occurred which were attributable to the PMT procedure. Right ventricular size and function improved in the majority of patients following the PMT procedure.
CONCLUSION: Using a conservative treatment approach of PMT for the treatment of massive PE carries a low periprocedural complication rate. The low morbidity was achieved without compromising clinical outcome, documented by an in-hospital mortality of 15%. PMT using a conservative treatment approach may result in comparable mortality, but lower morbidity than PMT using more aggressive, angiographically guided treatment strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18973510     DOI: 10.1111/j.1540-8183.2008.00405.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  4 in total

1.  Management of pulmonary embolism with rheolytic thrombectomy.

Authors:  Lisa Ferrigno; Robert Bloch; Judson Threlkeld; Thomas Demlow; Raman Kansal; Riyad Karmy-Jones
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

2.  Extracorporeal Membrane Oxygenation-First Strategy for Acute Life-Threatening Pulmonary Embolism.

Authors:  Zhenjie Liu; Jinyi Chen; Xin Xu; Fen Lan; Minzhi He; Changming Shao; Yongshan Xu; Pan Han; Yibing Chen; Yongbin Zhu; Man Huang
Journal:  Front Cardiovasc Med       Date:  2022-06-03

3.  Prevalence, Trends, and Outcomes of Pulmonary Embolism Treated with Mechanical and Surgical Thrombectomy from a Nationwide Inpatient Sample.

Authors:  Shalini Raghupathy; Achala Prashant Barigidad; Raydiene Doorgen; Shrestha Adak; Rohma Rafique Malik; Gaurav Parulekar; Jeet Janak Patel; Santh Prakash Lanka; George Mohan Varghese; Mohammed Rashid; Urvish Patel; Achint Patel; Ya-Ching Hsieh
Journal:  Clin Pract       Date:  2022-03-13

4.  Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy.

Authors:  Matjaz Bunc; Klemen Steblovnik; Simona Zorman; Peter Popovic
Journal:  Radiol Oncol       Date:  2020-02-14       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.